Normal view MARC view ISBD view

Generic screening as an integral part of quality management. [electronic resource]

By:

Chirico-Post, J A

Contributor(s):

Producer: 19921022Description: 36-41 p. digitalISSN:

0885-713X

Subject(s):

Online resources:

Available from publisher's website

In: Quality assurance and utilization review : official journal of the American College of Utilization Review Physicians vol. 5

Tags from this library: No tags from this library for this title. Log in to add tags.

Average rating: 0.0 (0 votes)

No physical items for this record

Publication Type: Journal Article

There are no comments on this title.

to post a comment.

Back to results

2021 17-AAG mediated targeting of Hsp90 limits tert activity in peritoneal sarcoma related malignant ascites by downregulating cyclin D1 during cell cycle entry.
by Chaklader, M
2022 Intracellular degradation of misfolded tau protein induced by geldanamycin is associated with activation of proteasome.
by Opattova, Alena
2023 A ligand-specific kinetic switch regulates glucocorticoid receptor trafficking and function.
by Trebble, Peter J
2024 A serotype 5/3 adenovirus expressing MDA-7/IL-24 infects renal carcinoma cells and promotes toxicity of agents that increase ROS and ceramide levels.
by Park, Margaret A
2025 Exome sequencing of hepatocellular carcinomas identifies new mutational signatures and potential therapeutic targets.
by Schulze, Kornelius
2026 Ombitasvir, paritaprevir co-dosed with ritonavir, dasabuvir, and ribavirin for hepatitis C in patients co-infected with HIV-1: a randomized trial.
by Sulkowski, Mark S
2027 Childhood facial vitiligo: how intractable is it?
by Kim, S A
2028 HSP27 knockdown produces synergistic induction of apoptosis by HSP90 and kinase inhibitors in glioblastoma multiforme.
by Belkacemi, Louiza
2029 HSP90 affects the stability of BMAL1 and circadian gene expression.
by Schneider, Rebecca
2030 ABT-450/r-ombitasvir and dasabuvir with ribavirin for hepatitis C with cirrhosis.
by Poordad, Fred
2031 Falling up stairs.
by Marshall, George
2032 Effects of 17-AAG on the cell cycle and apoptosis of H446 cells and the associated mechanisms.
by Zhao, Xuerong
2033 Glecaprevir/Pibrentasvir in patients with hepatitis C virus genotype 1 or 4 and past direct-acting antiviral treatment failure.
by Poordad, Fred
2034 Sofosbuvir/Velpatasvir/Voxilaprevir for patients with HCV who previously received a Sofosbuvir/Velpatasvir-containing regimen: Results from a retreatment study.
by Ruane, Peter
2035 Investigation on the binding mechanism of loratinib with the c-ros oncogene 1 (ROS1) receptor tyrosine kinase via molecular dynamics simulation and binding free energy calculations.
by Wu, Xiaoyun
2036 Hsp70 Binds to the Androgen Receptor N-terminal Domain and Modulates the Receptor Function in Prostate Cancer Cells.
by Dong, Jun
2037 Inhibition of c-myc gene expression in murine lymphoblastoma cells by geldanamycin and herbimycin, antibiotics of benzoquinoid ansamycin group.
by Yamaki, H
2038 Tyrosine kinase inhibitor herbimycin A reduces the stability of cyclin-dependent kinase Cdk6 protein in T-cells.
by Akagi, T
2039 Inhibitors of anchorage-independent growth affect the growth of transformed cells on poly(2-hydroxyethyl methacrylate)-coated surfaces.
by Fukazawa, H
2040 Protein tyrosine kinase inhibition blocks granule exocytosis and cytolytic function of lymphokine-activated killer cells.
by Frederick, M J